DOD Biotech Balance Sheet Health
Financial Health criteria checks 5/6
DOD Biotech has a total shareholder equity of THB874.9M and total debt of THB87.1M, which brings its debt-to-equity ratio to 10%. Its total assets and total liabilities are THB1.2B and THB328.8M respectively.
Key information
10.0%
Debt to equity ratio
฿87.08m
Debt
| Interest coverage ratio | n/a |
| Cash | ฿75.71m |
| Equity | ฿874.92m |
| Total liabilities | ฿328.82m |
| Total assets | ฿1.20b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DOD-R's short term assets (THB471.9M) exceed its short term liabilities (THB242.1M).
Long Term Liabilities: DOD-R's short term assets (THB471.9M) exceed its long term liabilities (THB86.7M).
Debt to Equity History and Analysis
Debt Level: DOD-R's net debt to equity ratio (1.3%) is considered satisfactory.
Reducing Debt: DOD-R's debt to equity ratio has reduced from 10.4% to 10% over the past 5 years.
Debt Coverage: DOD-R's debt is well covered by operating cash flow (66.1%).
Interest Coverage: Insufficient data to determine if DOD-R's interest payments on its debt are well covered by EBIT.